Uptake, benefits of and barriers to safer crack use kit (SCUK) distribution programmes in Victoria, Canada--a qualitative exploration.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 21700443)

Published in Int J Drug Policy on June 22, 2011

Authors

Andrew Ivsins1, Eric Roth, Nadine Nakamura, Mel Krajden, Benedikt Fischer

Author Affiliations

1: Department of Sociology, University of Victoria, Victoria, BC, Canada.

Articles by these authors

The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68

Identification of severe acute respiratory syndrome in Canada. N Engl J Med (2003) 14.29

Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis (2004) 4.29

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA (2013) 3.06

Novel avian influenza H7N3 strain outbreak, British Columbia. Emerg Infect Dis (2004) 2.90

In poor families, mothers' milk is richer for daughters than sons: a test of Trivers-Willard hypothesis in agropastoral settlements in Northern Kenya. Am J Phys Anthropol (2012) 2.81

Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. CMAJ (2009) 2.51

Hepatitis C virus reinfection in injection drug users. Hepatology (2006) 2.25

Changes in illicit opioid use across Canada. CMAJ (2006) 2.20

Crack use as a public health problem in Canada: call for an evaluation of 'safer crack use kits'. Can J Public Health (2005) 2.17

Should heroin be prescribed to heroin misusers? Yes. BMJ (2008) 1.96

Modeling control strategies of respiratory pathogens. Emerg Infect Dis (2005) 1.79

Use of other opioids during methadone therapy: a population-based study. Addiction (2012) 1.72

Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug Alcohol Depend (2007) 1.64

Problems with the fast-check HIV rapid test kits. CMAJ (2002) 1.64

Drug treatment courts in Canada: an evidence-based review. HIV AIDS Policy Law Rev (2007) 1.59

Burden of disease and cost of chronic hepatitis C infection in Canada. Can J Gastroenterol Hepatol (2014) 1.59

A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis (2012) 1.58

Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users. Drug Alcohol Depend (2006) 1.51

Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Can J Gastroenterol (2007) 1.44

Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada. CMAJ (2007) 1.43

Prostitutes are people too. Lancet (2005) 1.38

Drug policy and the public good: evidence for effective interventions. Lancet (2012) 1.37

The costs of alcohol, illegal drugs, and tobacco in Canada, 2002. J Stud Alcohol Drugs (2007) 1.30

Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence. Addict Behav (2005) 1.27

Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009. Drug Alcohol Depend (2010) 1.26

Proportional hazards frailty models for recurrent methadone maintenance treatment. Am J Epidemiol (2009) 1.26

Reinfection with hepatitis C virus following sustained virological response in injection drug users. J Gastroenterol Hepatol (2010) 1.26

Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis (2014) 1.23

A qualitative exploration of prescription opioid injection among street-based drug users in Toronto: behaviours, preferences and drug availability. Harm Reduct J (2008) 1.19

A generic concept for the implementation of medical image retrieval systems. Int J Med Inform (2007) 1.18

Prescription drug abuse in Canada and the diversion of prescription drugs into the illicit drug market. Can J Public Health (2005) 1.18

Determinants of health-related quality of life of opiate users at entry to low-threshold methadone programs. Eur Addict Res (2006) 1.15

Methamphetamine injection independently predicts hepatitis C infection among street-involved youth in a Canadian setting. J Adolesc Health (2008) 1.15

Substitution therapy for heroin addiction. Subst Use Misuse (2002) 1.13

Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program. AIDS Educ Prev (2007) 1.13

Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection. J Gastroenterol Hepatol (2012) 1.13

The importance of environmental modifiers of the relationship between substance use and harm. Addiction (2004) 1.10

Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada. J Urban Health (2004) 1.10

Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. Am J Gastroenterol (2009) 1.10

Feasibility of self-collection of specimens for human papillomavirus testing in hard-to-reach women. CMAJ (2007) 1.08

Genetic diversity as a marker for timing infection in HIV-infected patients: evaluation of a 6-month window and comparison with BED. J Infect Dis (2012) 1.08

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial). BMC Cancer (2010) 1.07

Feasibility and outcome of HCV treatment in a Canadian federal prison population. Am J Public Health (2005) 1.07

Impact of universal preadolescent vaccination against hepatitis B on antenatal seroprevalence of hepatitis B markers in British Columbia women. CMAJ (2003) 1.06

Self-perceived health among Canadian opiate users: a comparison to the general population and to other chronic disease populations. Can J Public Health (2004) 1.05

Multiple viral hepatitis in injection drug users and associated risk factors. J Gastroenterol Hepatol (2007) 1.04

Coordinated response to SARS, Vancouver, Canada. Emerg Infect Dis (2006) 1.04

Age of recipient and number of doses differentially impact human B and T cell immune memory responses to HPV vaccination. Vaccine (2012) 1.04

Assessing the prevalence of nonmedical prescription opioid use in the general Canadian population: methodological issues and questions. Can J Psychiatry (2010) 1.02

Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents. Liver Int (2013) 1.01

Use and nonmedical use of prescription opioid analgesics in the general population of Canada and correlations with dispensing levels in 2009. Pain Res Manag (2013) 1.00

How many people in Canada use prescription opioids non-medically in general and street drug using populations? Can J Public Health (2009) 0.99

Illicit opioid use and treatment for opioid dependence: challenges for Canada and beyond. Can J Psychiatry (2006) 0.98

Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016. Euro Surveill (2016) 0.98

Illicit opioid use in the 21st century: witnessing a paradigm shift? Addiction (2007) 0.97

Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia. BJOG (2003) 0.97

The Second Canadian Symposium on hepatitis C virus: a call to action. Can J Gastroenterol (2013) 0.96

Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes. Can J Public Health (2011) 0.96

Process monitoring of an HIV treatment as prevention program in British Columbia, Canada. J Acquir Immune Defic Syndr (2014) 0.96

HCV co-infection in HIV positive population in British Columbia, Canada. BMC Public Health (2010) 0.95

Key drug use, health and socio-economic characteristics of young crack users in two Brazilian cities. Int J Drug Policy (2013) 0.95

An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus. Can J Infect Dis Med Microbiol (2006) 0.95

An association between cytomegalovirus infection and pre-eclampsia: a case-control study and data synthesis. Acta Obstet Gynecol Scand (2010) 0.94

Harms of prescription opioid use in the United States. Subst Abuse Treat Prev Policy (2014) 0.94

Prescription opioid abuse: what is the real problem and how do we fix it? Can Fam Physician (2011) 0.94

Mortality among British Columbians testing for hepatitis C antibody. BMC Public Health (2013) 0.94

Parvovirus B19 in an immunocompetent adult patient with acute liver failure: an underdiagnosed cause of acute non-A-E viral hepatitis. Can J Gastroenterol (2005) 0.93

Crack use in North American cities: the neglected 'epidemic'. Addiction (2007) 0.92

Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review. Can J Psychiatry (2011) 0.92

Capacity enhancement of hepatitis C virus treatment through integrated, community-based care. Can J Gastroenterol (2008) 0.92

A generic concept for the implementation of medical image retrieval systems. Stud Health Technol Inform (2005) 0.92

Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians. Can J Gastroenterol (2008) 0.91

Estimating the economic value of British Columbia's domestic cannabis market: implications for provincial cannabis policy. Int J Drug Policy (2012) 0.90

The hotel study: multimorbidity in a community sample living in marginal housing. Am J Psychiatry (2013) 0.90

Assessing the prevalence of non-medical prescription opioid use in the Canadian general adult population: evidence of large variation depending on survey questions used. BMC Psychiatry (2013) 0.90

Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a viruses. Euro Surveill (2016) 0.88

Self-collected versus clinician-collected sampling for sexually transmitted infections: a systematic review and meta-analysis protocol. Syst Rev (2013) 0.88

HIV Community Viral Load and Factors Associated With Elevated Viremia Among a Community-Based Sample of Men Who Have Sex With Men in Vancouver, Canada. J Acquir Immune Defic Syndr (2016) 0.87

Benefits and constraints of intimate partnerships for HIV positive sex workers in Kibera, Kenya. Int J Equity Health (2013) 0.87

Non-medical use of prescription opioids among Ontario adults: data from the 2008/2009 CAMH Monitor. Can J Public Health (2011) 0.87

Targeting screening and social marketing to increase detection of acute HIV infection in men who have sex with men in Vancouver, British Columbia. AIDS (2013) 0.87

Increasing public support for supervised injection facilities in Ontario, Canada. Addiction (2014) 0.86

Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada. Int J Drug Policy (2007) 0.86

Bridging the integration gap between imaging and information systems: a uniform data concept for content-based image retrieval in computer-aided diagnosis. J Am Med Inform Assoc (2011) 0.86

Detection of influenza H7N9 virus: all molecular tests are not equal. J Clin Microbiol (2013) 0.86

Personalized risk assessment of drug-related harm is associated with health outcomes. PLoS One (2013) 0.85

Structural barriers in the context of opiate substitution treatment in Germany--a survey among physicians in primary care. Subst Abuse Treat Prev Policy (2013) 0.85

Patterns of opioid and cocaine co-use: a descriptive study in a Canadian sample of untreated opioid-dependent individuals. Exp Clin Psychopharmacol (2005) 0.85

A narrative review of recent developments in knowledge translation and implications for mental health care providers. Can J Psychiatry (2014) 0.85

Methadone use in relation to hepatitis C virus testing in British Columbia. Can J Public Health (2011) 0.84

Fentanyl use among street drug users in Toronto, Canada: behavioural dynamics and public health implications. Int J Drug Policy (2008) 0.84

Does cirrhosis affect quality of life in hepatitis C virus-infected patients? Liver Int (2009) 0.84

Exploring sex differences in drug use, health and service use characteristics among young urban crack users in Brazil. Int J Equity Health (2014) 0.84

High levels of opioid analgesic co-prescription among methadone maintenance treatment clients in British Columbia, Canada: results from a population-level retrospective cohort study. Am J Addict (2014) 0.84

Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, Canada. Int J Cancer (2008) 0.83

Towards targeted screening for acute HIV infections in British Columbia. J Int AIDS Soc (2011) 0.83

SARS: a quality management test of our public health safety net. Qual Manag Health Care (2004) 0.83

Prevalence and associated factors of hepatitis C infection (HCV) in a multi-site Canadian population of illicit opioid and other drug users (OPICAN). Can J Public Health (2007) 0.83